Mercado de Bioinformática Ásia-Pacífico – Tendências e Previsão da Indústria para 2029

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista  Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado de Bioinformática Ásia-Pacífico – Tendências e Previsão da Indústria para 2029

  • Medical Devices
  • Publish Reports
  • Aug 2022
  • Asia-Pacific
  • 350 Páginas
  • Número de tabelas: 295
  • Número de figuras: 48

Asia Pacific Apac Bioinformatics Market

Tamanho do mercado em biliões de dólares

CAGR :  % Diagram

Diagram Período de previsão
2023 –2029
Diagram Tamanho do mercado (ano base )
US$ MILHÕES
Diagram Tamanho do mercado ( Ano de previsão)
USD 11.30 Billion
Diagram CAGR
%
Diagram Principais participantes do mercado
  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • QIAGEN SOPHiA GENETICS
  • BGI Eurofins Scientific

>Mercado de Bioinformática Ásia-Pacífico, por tipo (ferramentas de gestão de conhecimento, software e serviços de bioinformática), setor (biotecnologia médica, académicos, biotecnologia animal, biotecnologia agrícola, biotecnologia ambiental, biotecnologia forense e outros), aplicação (genómica e desenvolvimento de medicamentos, proteómica, Estudos Evolutivos, Estudos Agrícolas, Ciências Veterinárias, Metabolómica , Transcriptómica e Outros), Modo de Compra (Compra em Grupo e Compra Individual), Método (Genómica e Proteómica) Utilizador Final, (Institutos Académicos e de Investigação, Organização de Investigação Clínica, Empresas de Biotecnologia e Farmacêuticas , laboratórios de investigação, hospitais e outros) - Tendências e previsões do setor para 2029.

Mercado de Bioinformática Ásia-Pacífico

Análise e insights do mercado de bioinformática da Ásia-Pacífico

Espera-se que o aumento da procura de bioinformática computacional avançada, transcriptómica, ferramentas protémicas na investigação de Biologia Molecular seguida pelo aumento dos requisitos para a bioinformática integrada em diagnósticos proteómicos, genómicos e clínicos, e numerosas organizações de bioinformática que fornecem recursos de outsourcing impulsionem o crescimento do mercado.

Mercado de Bioinformática Ásia-Pacífico

Mercado de Bioinformática Ásia-Pacífico

No entanto, espera-se que a falta de conhecimentos qualificados e formados para utilizar as ferramentas computacionais restrinja o crescimento do segmento.

Espera-se que o aumento da parceria com os players do mercado para a utilização de software de bioinformática impulsione o crescimento do mercado. A Data Bridge Market Research analisa que o mercado de bioinformática da Ásia-Pacífico crescerá a um CAGR de 17,8% durante o período de previsão de 2022 a 2029.

Métrica de reporte

Detalhes

Período de previsão

2022 a 2029

Ano base

2021

Anos históricos

2020 (personalizável para 2019 - 2014)

Unidades Quantitativas

Receita em milhões de dólares, preços em dólares

Segmentos cobertos

Por Tipo (Ferramentas de Gestão do Conhecimento, Software e Serviços de Bioinformática), Setor (Biotecnologia Médica, Académico, Biotecnologia Animal, Biotecnologia Agrícola, Biotecnologia Ambiental, Biotecnologia Forense e Outros), Aplicação (Genómica e Desenvolvimento de Medicamentos, Proteómica, Estudos Evolutivos , Estudos Agrícolas, Ciência Veterinária, Metabolómica, Transcriptómica e Outros), Modo de Compra (Compra em Grupo e Compra Individual), Método (Genómica e Proteómica) Utilizador Final, (Institutos Académicos e de Investigação, Organização de Investigação Clínica, Empresas Biotecnológicas e Farmacêuticas, Laboratórios de Investigação, Hospitalar e Outros)

Países abrangidos

China, Japão, Índia, Coreia do Sul, Austrália, Singapura, Tailândia, Malásia, Indonésia, Filipinas, Resto da Ásia-Pacífico

Participantes do mercado abrangidos

Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Waters Corporation, Partek Incorporated, Dassault Système, Bayer AG, PerkinElmer Inc., Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam, Strand Life Science, GenoFAB, Inc.

Definição de mercado

Bioinformatics combines computer programming, big data, and Molecular Biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.

From genetics to toxicology to mycology and radiobiology, there are scores of branches of Biology to specialize in. And out of the many, Bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of Computer Science, Statistics, and Biology to develop software applications for understanding biological data like DNA sequencing, protein analysis, evolutionary genetics, etc.

In the coming future, important decisions related to bioinformatics on drug discovery will be made by individuals who not only understand the biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify quality targets

Asia-Pacific Bioinformatics Market Dynamics

Drivers

  • Increasing Public-Private Sector Funding For Bioinformatics

In order to improve the workflow for bioinformatics, the federal agencies and the public and private agencies are providing funds to carry out bioinformatics projects and to scientists for research. It is important to approach possible funders with a clear proposal and strategy of what is to be achieved in terms of bioinformatics capacity building in the institution as well as the intended outputs and outcomes.

For instance;

  • In April 2022, Illumina, Inc. initiated the six-month cyclic funding in the San Francisco Bay Area or Cambridge, the U.K., for bioinformatics start-up
  • In October 2020, SOPHiA GENETICS raised USD 110 million for financing for the next stage of its expansion, with a focus on supporting the growing clinical and biopharma demand for Data-Driven Medicine worldwide

The funding by the public and private sectors would result in the rise of bioinformatics startups and projects. The funding would expedite and expand the institute's technical infrastructure. This includes setting up new data storage solutions and scaling existing data resources. The funding will also be used to provide secure, shared analysis platforms for major research collaborations. Hence the public-private sector funding for bioinformatics is expected to drive market growth.

  • Use of Bioinformatics in Personalized Medicine

The growth curve for  bioinformatics market clinical applications is following an upward trend as established applications are gaining momentum and new ones are finding a foothold. Product development in the past years has helped the market size to grow. This also shows the support of the regulatory agency for allowing these products in the market.

For instance-

  • In June 2021, Agilent Technologies, Inc. released a new exome design called Sure Select Human All Exon V8 that offers specific content and coverage of protein-coding areas from Refuses, CCDS, and GENCODE. Additionally, it includes exons that are challenging to capture and the TERT promoter, which are neglected by competing exomes

The product development in recent years has shown the potential of these technologies, and the companies working in this market are trying to get the more advanced product in the market, which is expected to create a lucrative opportunity for market growth in the forecast period.

Opportunities

  • Strategic Initiatives by Market Players

Bioinformatics delivers purposeful biological information, as it is a part of life science dealing with the comprehension and planning of genomes. A genome is the complex arrangement of genetic sets present in a cell or a whole living being. Personalized medicine is a combinatorial way to deal with individual-specific health care. The patient-specific medication development advanced through bioinformatics tools.

For instance-

  • In December 2020, Quest Diagnostics Incorporated invested in Structural Bioinformatics, A Leader in Computational Proteomics and Structural Pharmacogenomics. The investment resulted in the joint development of a series of database modules of the novel, structurally variant proteins and market these products directly to the pharmaceutical and biotechnology industry for use in the development of personalized medicine
  • In 2019, BGI announced that Flow Pharma had selected BGI (A subsidiary of BGI Group) for developing the use of NSG in Drug Development

Hence the growing prevalence of chronic disease and increased drug-resistance issues in traditional medication have generated the demand for increasing bioinformatics in drug development. This is expected to be one of the major factors expected to drive the market growth in the forecast period.

  • Advancement in bioinformatics technology

The dimensions and cost of bioinformatics platforms and instruments are decreasing, allowing easier uptake by public health laboratories. Although currently, bioinformatics requires highly specialized equipment and substantially skilled staff to analyze the data, it is unlikely that the bioinformatics revolution has finished. With rising technology, up-gradation of instruments and techniques is also needed. Moreover, the bioinformatics market has a vast potential to upgrade various applications, and there are high chances of advancing bioinformatics techniques in the forecast period.

  • E-Health.

E-health equipment and technologies. Processing of information in e-health. Services and applications for telemedicine and e-health. Image processing in medicine. Medical imaging approaches using video. Combining traditional treatment with electronic health

With time, technological advancements put pressure on manufacturers and researchers to change instruments and techniques to cope with modern problems. Thus bioinformatics has the potential to get updated with time and is expected to create opportunities for the new player and existing players to bring a new product to the market.

Restraints/Challenges

  • Challenges to Implementing Bioinformatics Technology in The Clinical Labs

Bioinformatics technologies can perform massively complicated biological data analysis. This capacity simultaneously facilitates the computational tools for the organization and analysis of biological data, which helps improve diagnostic screening. The application of these powerful technologies in a clinical laboratory poses a challenge because of the data's scope, quantity, and medico-technical consequences.

Various challenges of implementing next-generation sequencing in the clinical laboratory are as follows-

  • One of the first areas where problems can creep in is often the most overlooked: "sample quality". Although platforms are often tested and compared using highly curated samples (such as the reference material from the Genome in a Bottle Consortium), real-world samples often present much more of a challenge and hence act as a challenge for the rise in demand.
  • High turn-around time is also a major challenge for the instruments working in this market.
  • Library Preparation

The above challenge poses complications for adopting bioinformatics in the clinical laboratory, due to which fewer clinical laboratories are adopting this technology. Thus, the challenges of implementing bioinformatics technology in the clinical lab are expected to hamper the market growth.

  • Cyber Security Concerns in Bioinformatics

Era software is known to contain vulnerabilities caused by imperfect code and misconfiguration. NGS-related software used to operate sequencing and laboratory equipment or carry out bioinformatics analyzes is no exception. Software vulnerabilities are exploited to gain unauthorized access to computer systems or networks, leak data, crash or otherwise disrupt various services.

However, the increasing computerization of DNA technology and biotechnology raises new bio-cyber security concerns. Vulnerabilities typically associated with traditional computer systems -- like the processing of untrusted input, side-channel leaks, poor authentication, falsified data, and vulnerabilities in cyber-physical systems -- now exist in biotechnology. The emerging bio-cyber security threats have threatened the DNA-Information Systems in bioinformatics.

For instance;

  • In 2020, The REvil or Sodinokibi ransomware group will take the credit for hacking and stealing 1 Terabyte (TB) of data from 10x Genomics which is for COVID-19 research
  • In 2018, Genomics England shifted genetic blueprint data for its 100,000 Genomes Project after being targeted by cyber-attacks from foreign parties. This allows the breach of data and can lead to misuse of individual genome

COVID-19 Impact on the Asia-Pacific Bioinformatics Market

During the pandemic, the Asia-Pacific bioinformatics sector is one that focuses on using a combination of biology and information technology. Biological data is analyzed and transformed at the heart of the industry using IT techniques. Bioinformatics has always had huge potential in providing essential support to many areas of scientific research. The bioinformatics industry in Asia-Pacific has experienced rapid growth opportunities before the pandemic owing to efficient bioinformatics tools, which can handle large volumes of biological data.

The tools that bioinformatics can provide allow scientists to get to grips with larger data sets and to mine and analyze them to discover crucial information that could lead to key discoveries. In recent years, genetics and genomes have been the primary focus of Bioinformatics, including comparative genomics, DNA microarrays, and functional genomics.  The COVID-19 pandemic has seen widespread application of genomic approaches to understand the epidemiology and evolution of SARS-CoV-2 virus. The accelerated efforts to sequence SARS-CoV-2 genomes picked up pace following the initial genome sequencing of the virus from a patient in Wuhan, the epicenter for the pandemic with substantial increases at the emergence of variants of the SARS-CoV-2 virus.

Recent Development

  • In March 2022, Thermo Fisher Scientific Inc launched the CE-IVD Marked Next-Generation Sequencing (NGS) Instrument for Use in Clinical Labs. The CE-IVD Marked Next-Generation Sequencing Instrument is used to perform diagnostic testing and clinical research on a single instrument. The launch of the instrument resulted in the addition of a new product in the product range and the distribution of the NGS instrument, which is expected to increase the product revenue.

Asia-Pacific Bioinformatics Market Scope

Asia-Pacific bioinformatics market is segmented on the basis of six segments: type, sector, application, purchase mode, genomics, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Knowledge Management Tools
  • Bioinformatics Software
  • Services

On the basis of type, the Asia-Pacific bioinformatics market is segmented into knowledge management tools, bioinformatics software, and services.

Sector

  • Medical biotechnology
  • Academics
  • Animal Biotechnology
  • Agricultural biotechnology
  • Environmental Biotechnology
  • Forensic biotechnology
  • Others

On the basis of sector, the Asia-Pacific bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others.

Application

  • Genomics and Drug Development
  • Proteomics
  • Evolutionary Studies
  • Agricultural Studies
  • Veterinary Science
  • Metabolomics
  • Transcriptomics
  • Others

On the basis of application, the Asia-Pacific bioinformatics market is segmented into genomics and drug development, proteomics, evolutionary studies, agricultural studies, veterinary science, metabolomics, transcriptomics, and others.

Purchase Mode

  • Group Purchase
  • Individual Purchase

On the basis of purchase mode, the Asia-Pacific bioinformatics market is segmented into group purchases and individual purchases.

Method

  • Genomics
  • Proteomics

On the basis of method, the Asia-Pacific bioinformatics market is segmented into genomics and proteomics.

End User

  • Research and Academic Institutes
  • Clinical Research Organization
  • Biotech and Pharmaceutical Companies
  • Research Laboratories
  • Hospital
  • Others

Mercado da Bioinformática

On the basis of end-user, the Asia-Pacific bioinformatics market is segmented into research and academic institutes, clinical research organizations, biotech and pharmaceutical companies, research laboratories, hospitals, and others.

Asia-Pacific Bioinformatics Market Regional Analysis/Insights

Asia-Pacific bioinformatics market is analyzed, and regions provide market size insights and trends, type, sector, application, purchase mode, genomics, and end-user, as referenced above.

The countries covered in the Asia-Pacific bioinformatics market report are China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific.

China is expected to dominate the market due to a rise in the incidence of rise in research and development activity and due to integrated bioinformatics requirements in proteomic, genomic, & clinical diagnostics, combined with the surging demand for advanced computational tools in biological research.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of  brands and their challenges faced due to large or scarce competition from local and domestic brands impact sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Asia-Pacific Bioinformatics Market Share Analysis

O panorama competitivo do mercado de bioinformática da Ásia-Pacífico fornece detalhes sobre o concorrente. Os detalhes incluem a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença na Ásia-Pacífico, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produtos, largura do produto, e amplitude e domínio de aplicação. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado de Bioinformática da Ásia-Pacífico.

Alguns dos principais players que operam no mercado da bioinformática Ásia-Pacífico são a Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Waters Corporation, Partek Incorporated, Dassault Système , Bayer AG, PerkinElmer Inc., Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam, Strand Life Science, GenoFAB, Inc.


SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE ASIA PACIFIC BIOINFORMATICS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHIC SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 RESEARCH METHODOLOGY

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MULTIVARIATE MODELLING

2.8 TYPE SEGMENT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 THE CATEGORY VS TIME GRID

2.13 SECONDARY SOURCES

2.14 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL

4.2 PORTER'S FIVE FORCES MODEL

5 REGULATIONS OF THE ASIA PACIFIC BIOINFORMATICS MARKET

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 DECREASE IN THE COST OF GENETIC SEQUENCING PER BASE

6.1.2 GROWING NEED FOR BIOINFORMATICS

6.1.3 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS

6.1.4 USE OF BIOINFORMATICS IN PERSONALIZED MEDICINE

6.1.5 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS

6.2 RESTRAINTS

6.2.1 HIGH COST OF INSTRUMENTATION

6.2.2 DIFFICULTY IN CLINICAL BIOINFORMATICS ANALYSIS

6.2.3 CYBER SECURITY CONCERNS IN BIOINFORMATICS

6.3 OPPORTUNITIES

6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER

6.3.2 PRODUCT DEVELOPMENT IN RECENT YEARS

6.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY

6.4 CHALLENGES

6.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM BIOINFORMATICS TECHNOLOGY

6.4.2 CHALLENGES TO IMPLEMENTING BIOINFORMATICS TECHNOLOGY IN THE CLINICAL LABS

7 ASIA PACIFIC BIOINFORMATICS MARKET, BY TYPE

7.1 OVERVIEW

7.2 SERVICES

7.2.1 DIAGNOSTICS CONSULTATION

7.2.2 DATA ANALYSIS

7.2.2.1 STRUCTURAL

7.2.2.2 FUNCTIONAL

7.3 BIOINFORMATICS SOFTWARE

7.3.1 INFORMATICS INFRASTRUCTURE AND PIPELINE SETUP

7.3.2 SAMPLE AND EXPERIMENT MANAGEMENT

7.3.3 SEQUENCING DATA ANALYSIS

7.3.3.1 SEQUENCE ANALYSIS PLATFORM

7.3.3.2 SEQUENCE ALIGNMENT PLATFORM

7.3.3.3 SEQUENCE MANIPULATION PLATFORM

7.3.3.4 STRUCTURAL ANALYSIS PLATFORM

7.3.3.5 OTHERS

7.3.4 BIOLOGICAL DATA INTERPRETATION

7.3.5 SPECIALIZED BIOINFORMATICS APPLICATIONS

7.3.5.1 SINGLE CELL GENE EXPRESSION

7.3.5.2 GENE EXPRESSION

7.3.5.3 VARIANT DETECTION

7.3.5.4 CNV ANALYSIS

7.3.5.5 METAGENOMICS

7.3.5.6 METHYLATION

7.3.5.7 CHIP-SEQ

7.3.5.8 NON-CODING RNA EXPRESSION

7.3.5.9 OTHERS

7.3.6 OTHERS

7.4 KNOWLEDGE MANAGEMENT TOOLS

7.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS

7.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS

8 ASIA PACIFIC BIOINFORMATICS MARKET, BY SECTOR

8.1 OVERVIEW

8.2 MEDICAL BIOTECHNOLOGY

8.3 ACADEMICS

8.4 ANIMAL BIOTECHNOLOGY

8.5 AGRICULTURAL BIOTECHNOLOGY

8.6 ENVIRONMENTAL BIOTECHNOLOGY

8.7 FORENSIC BIOTECHNOLOGY

8.8 OTHERS

9 ASIA PACIFIC BIOINFORMATICS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 GENOMICS & DRUG DEVELOPMENT

9.2.1 SERVICES

9.2.2 SEQUENCING PLATFORMS

9.2.3 KNOWLEDGE MANAGEMENT TOOLS

9.2.4 GENOMICS & DRUG DEVELOPMENT BY TYPE

9.2.4.1 PREVENTIVE MEDICINE

9.2.4.2 MOLECULAR MEDICINE

9.2.4.3 PERSONALIZED MEDICINE

9.2.4.4 CHEMOINFORMATICS AND DRUG DESIGN

9.2.4.5 ANTIBIOTIC RESISTANCE

9.3 PROTEOMICS

9.3.1 SERVICES

9.3.2 SERVICES SEQUENCING PLATFORMS

9.3.3 KNOWLEDGE MANAGEMENT TOOLS

9.4 AGRICULTURAL STUDIES

9.4.1 SERVICES

9.4.2 SERVICES SEQUENCING PLATFORMS

9.4.3 KNOWLEDGE MANAGEMENT TOOLS

9.5 TRANSCRIPTOMICS

9.5.1 SERVICES

9.5.2 SERVICES SEQUENCING PLATFORMS

9.5.3 KNOWLEDGE MANAGEMENT TOOLS

9.6 METABOLOMICS

9.6.1 SERVICES

9.6.2 SERVICES SEQUENCING PLATFORMS

9.6.3 KNOWLEDGE MANAGEMENT TOOLS

9.7 EVOLUTIONARY STUDIES

9.7.1 SERVICES

9.7.2 SERVICES SEQUENCING PLATFORMS

9.7.3 KNOWLEDGE MANAGEMENT TOOLS

9.8 VETERINARY SCIENCE

9.8.1 SERVICES

9.8.2 SERVICES SEQUENCING PLATFORMS

9.8.3 KNOWLEDGE MANAGEMENT TOOLS

9.9 OTHERS

9.9.1 SERVICES

9.9.2 SERVICES SEQUENCING PLATFORMS

9.9.3 KNOWLEDGE MANAGEMENT TOOLS

10 ASIA PACIFIC BIOINFORMATICS MARKET, BY PURCHASE MODE

10.1 OVERVIEW

10.2 GROUP PURCHASE

10.3 INDIVIDUAL PURCHASE

11 ASIA PACIFIC BIOINFORMATICS MARKET, BY METHOD

11.1 OVERVIEW

11.2 GENOMICS

11.2.1 DNA

11.2.2 RNA

11.3 PROTEOMICS

12 ASIA PACIFIC BIOINFORMATICS MARKET, BY END USER

12.1 OVERVIEW

12.2 RESEARCH AND ACADEMIC INSTITUTES

12.3 CLINICAL RESEARCH ORGANIZATION

12.4 BIOTECH AND PHARMACEUTICAL COMPANIES

12.5 RESEARCH LABORATORIES

12.6 HOSPITALS

12.7 OTHERS

13 ASIA PACIFIC BIOINFORMATICS MARKET, BY REGION

13.1 ASIA-PACIFIC

13.1.1 CHINA

13.1.2 JAPAN

13.1.3 INDIA

13.1.4 SOUTH KOREA

13.1.5 AUSTRALIA

13.1.6 SINGAPORE

13.1.7 THAILAND

13.1.8 MALAYSIA

13.1.9 INDONESIA

13.1.10 PHILIPPINES

13.1.11 REST OF ASIA-PACIFIC

14 ASIA PACIFIC BIOINFORMATICS MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 BAYER AG

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 THERMO FISHER SCIENTIFIC INC

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 EUROFINS SCIENTIFIC

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 DASSAULT SYSTÈMES

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENTS

16.5 AGILENT TECHNOLOGIES, INC

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENTS

16.6 ASTRIDBIO TECHNOLOGIES INC.

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENTS

16.7 BGI (A SUBSIDIARY OF BGI GROUP)

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 BIOBAM

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENTS

16.9 DNANEXUS INC.

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENTS

16.1 DNASTAR

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENTS

16.11 GENOFAB, INC

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 ILLUMINA, INC

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENTS

16.13 PARTEK INCORPORATED

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENTS

16.14 PERKINELMER INC.

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENTS

16.15 QIAGEN

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.16 QUEST DIAGNOSTICS INCORPORATED (2021)

16.16.1 COMPANY SNAPSHOT

16.16.2 REVENUE ANALYSIS

16.16.3 PRODUCT PORTFOLIO

16.16.4 RECENT DEVELOPMENTS

16.17 SEVEN BRIDGES GENOMICS

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 SOPHIA GENETICS

16.18.1 COMPANY SNAPSHOT

16.18.2 REVENUE ANALYSIS

16.18.3 PRODUCT PORTFOLIO

16.18.4 RECENT DEVELOPMENTS

16.19 STRAND LIFE SCIENCES

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 WATERS CORPORATION

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

Lista de Tabela

TABLE 1 BIOINFORMATICSCOST PER SAMPLE

TABLE 2 ASIA PACIFIC BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 3 ASIA PACIFIC SERVICES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 ASIA PACIFIC SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 5 ASIA PACIFIC DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 6 ASIA PACIFIC BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 ASIA PACIFIC BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 8 ASIA PACIFIC SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 9 ASIA PACIFIC SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 10 ASIA PACIFIC KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 ASIA PACIFIC KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 ASIA PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 13 ASIA PACIFIC MEDICAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 ASIA PACIFIC ACADEMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 ASIA PACIFIC ANIMAL TECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 ASIA PACIFIC AGRICULTURAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 ASIA PACIFIC ENVIRONMENTAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 ASIA PACIFIC FORENSIC BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 ASIA PACIFIC OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 ASIA PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 21 ASIA PACIFIC GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 ASIA PACIFIC GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 23 ASIA PACIFIC GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 24 ASIA PACIFIC PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 ASIA PACIFIC PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 26 ASIA PACIFIC AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 ASIA PACIFIC AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 28 ASIA PACIFIC TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 ASIA PACIFIC TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 30 ASIA PACIFIC METABOLOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 ASIA PACIFIC METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 32 ASIA PACIFIC EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 ASIA PACIFIC EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 34 ASIA PACIFIC VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 ASIA PACIFIC VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 36 ASIA PACIFIC OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 ASIA PACIFIC OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 38 ASIA PACIFIC BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 39 ASIA PACIFIC GROUP PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 ASIA PACIFIC INDIVIDUAL PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 ASIA PACIFIC BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 42 ASIA PACIFIC GENOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 ASIA PACIFIC GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 44 ASIA PACIFIC PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 ASIA PACIFIC BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 46 ASIA PACIFIC RESEARCH AND ACADEMIC INSTITUTES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 47 ASIA PACIFIC CLINICAL RESEARCH ORGANIZATION IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 48 ASIA PACIFIC BIOTECH AND PHARMACEUTICAL COMPANIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 49 ASIA PACIFIC RESEARCH LABORATORIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 50 ASIA PACIFIC HOSPITALS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 ASIA PACIFIC OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 52 ASIA-PACIFIC BIOINFORMATICS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 53 ASIA-PACIFIC BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 ASIA-PACIFIC SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 55 ASIA-PACIFIC DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 56 ASIA-PACIFIC BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 57 ASIA-PACIFIC SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 58 ASIA-PACIFIC SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 59 ASIA-PACIFIC KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 60 ASIA-PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 61 ASIA-PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 62 ASIA-PACIFIC GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 63 ASIA-PACIFIC GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 64 ASIA-PACIFIC PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 65 ASIA-PACIFIC AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 66 ASIA-PACIFIC TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 67 ASIA-PACIFIC METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 68 ASIA-PACIFIC EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 69 ASIA-PACIFIC VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 70 ASIA-PACIFIC OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 71 ASIA-PACIFIC BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 72 ASIA-PACIFIC BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 73 ASIA-PACIFIC GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 74 ASIA-PACIFIC BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 75 CHINA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 76 CHINA SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 77 CHINA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 78 CHINA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 79 CHINA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 80 CHINA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 81 CHINA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 82 CHINA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 83 CHINA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 84 CHINA GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 85 CHINA GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 86 CHINA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 87 CHINA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 88 CHINA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 89 CHINA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 90 CHINA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 91 CHINA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 92 CHINA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 93 CHINA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 94 CHINA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 95 CHINA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 96 CHINA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 97 JAPAN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 98 JAPAN SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 99 JAPAN DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 100 JAPAN BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 101 JAPAN SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 JAPAN SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 103 JAPAN KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 JAPAN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 105 JAPAN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 106 JAPAN GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 107 JAPAN GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 108 JAPAN PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 109 JAPAN AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 110 JAPAN TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 111 JAPAN METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 112 JAPAN EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 113 JAPAN VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 114 JAPAN OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 115 JAPAN BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 116 JAPAN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 117 JAPAN GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 118 JAPAN BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 119 INDIA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 120 INDIA SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 121 INDIA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 122 INDIA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 123 INDIA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 124 INDIA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 125 INDIA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 126 INDIA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 127 INDIA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 128 INDIA GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 129 INDIA GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 130 INDIA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 131 INDIA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 132 INDIA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 133 INDIA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 134 INDIA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 135 INDIA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 136 INDIA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 137 INDIA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 138 INDIA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 139 INDIA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 140 INDIA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 141 SOUTH KOREA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 142 SOUTH KOREA SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 143 SOUTH KOREA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 144 SOUTH KOREA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 145 SOUTH KOREA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 146 SOUTH KOREA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 147 SOUTH KOREA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 148 SOUTH KOREA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 149 SOUTH KOREA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 150 SOUTH KOREA GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 151 SOUTH KOREA GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 152 SOUTH KOREA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 153 SOUTH KOREA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 154 SOUTH KOREA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 155 SOUTH KOREA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 156 SOUTH KOREA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 157 SOUTH KOREA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 158 SOUTH KOREA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 159 SOUTH KOREA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 160 SOUTH KOREA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 161 SOUTH KOREA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 162 SOUTH KOREA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 163 AUSTRALIA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 164 AUSTRALIA SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 165 AUSTRALIA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 166 AUSTRALIA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 167 AUSTRALIA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 168 AUSTRALIA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 169 AUSTRALIA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 170 AUSTRALIA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 171 AUSTRALIA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 172 AUSTRALIA GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 173 AUSTRALIA GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 174 AUSTRALIA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 175 AUSTRALIA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 176 AUSTRALIA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 177 AUSTRALIA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 178 AUSTRALIA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 179 AUSTRALIA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 180 AUSTRALIA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 181 AUSTRALIA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 182 AUSTRALIABIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 183 AUSTRALIA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 184 AUSTRALIA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 185 SINGAPORE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 186 SINGAPORE SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 187 SINGAPORE DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 188 SINGAPORE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 189 SINGAPORE SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 190 SINGAPORE SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 191 SINGAPORE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 192 SINGAPORE BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 193 SINGAPORE BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 194 SINGAPORE GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 195 SINGAPORE GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 196 SINGAPORE PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 197 SINGAPORE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 198 SINGAPORE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 199 SINGAPORE METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 200 SINGAPORE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 201 SINGAPORE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 202 SINGAPORE OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 203 SINGAPORE BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 204 SINGAPORE BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 205 SINGAPORE GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 206 SINGAPORE BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 207 THAILAND BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 208 THAILAND SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 209 THAILAND DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 210 THAILAND BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 211 THAILAND SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 212 THAILAND SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 213 THAILAND KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 214 THAILAND BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 215 THAILAND BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 216 THAILAND GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 217 THAILAND GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 218 THAILAND PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 219 THAILAND AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 220 THAILAND TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 221 THAILAND METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 222 THAILAND EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 223 THAILAND VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 224 THAILAND OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 225 THAILAND BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 226 THAILAND BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 227 THAILAND GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 228 THAILANDBIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 229 MALAYSIA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 230 MALAYSIA SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 231 MALAYSIA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 232 MALAYSIA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 233 MALAYSIA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 234 MALAYSIA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 235 MALAYSIA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 236 MALAYSIA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 237 MALAYSIA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 238 MALAYSIA GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 239 MALAYSIA GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 240 MALAYSIA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 241 MALAYSIA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 242 MALAYSIA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 243 MALAYSIA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 244 MALAYSIA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 245 MALAYSIA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 246 MALAYSIA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 247 MALAYSIA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 248 MALAYSIA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 249 MALAYSIA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 250 MALAYSIA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 251 INDONESIA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 252 INDONESIA SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 253 INDONESIA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 254 INDONESIA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 255 INDONESIA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 256 INDONESIA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 257 INDONESIA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 258 INDONESIA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 259 INDONESIA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 260 INDONESIA GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 261 INDONESIA GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 262 INDONESIA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 263 INDONESIA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 264 INDONESIA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 265 INDONESIA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 266 INDONESIA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 267 INDONESIA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 268 INDONESIA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 269 INDONESIA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 270 INDONESIA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 271 INDONESIA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 272 INDONESIA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 273 PHILIPPINES BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 274 PHILIPPINES SERVICES IN BIOINFORMATICSMARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 275 PHILIPPINES DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 276 PHILIPPINES BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 277 PHILIPPINES SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 278 PHILIPPINES SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 279 PHILIPPINES KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 280 PHILIPPINES BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 281 PHILIPPINES BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 282 PHILIPPINES GENOMICS AND DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 283 PHILIPPINES GENOMICS AND DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 284 PHILIPPINES PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 285 PHILIPPINES AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 286 PHILIPPINES TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 287 PHILIPPINES METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 288 PHILIPPINES EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 289 PHILIPPINES VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 290 PHILIPPINES OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 291 PHILIPPINES BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 292 PHILIPPINES BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 293 PHILIPPINES GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 294 PHILIPPINESBIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 295 REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

Lista de Figura

FIGURE 1 ASIA PACIFIC BIOINFORMATICS MARKET: SEGMENTATION

FIGURE 2 ASIA PACIFIC BIOINFORMATICS MARKET: GEOGRAPHIC SCOPE

FIGURE 3 ASIA PACIFIC BIOINFORMATICS MARKET: DATA TRIANGULATION

FIGURE 4 ASIA PACIFIC BIOINFORMATICS MARKET: SNAPSHOT

FIGURE 5 ASIA PACIFIC BIOINFORMATICS MARKET: BOTTOM-UP APPROACH

FIGURE 6 ASIA PACIFIC BIOINFORMATICS MARKET: TOP-DOWN APPROACH

FIGURE 7 ASIA PACIFIC BIOINFORMATICS MARKET: INTERVIEWS BY REGION AND DESIGNATION

FIGURE 8 ASIA PACIFIC BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA PACIFIC BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA PACIFIC BIOINFORMATICS MARKET: APPLICATION COVERAGE GRID

FIGURE 11 ASIA PACIFIC BIOINFORMATICS MARKET: THE CATEGORY VS TIME GRID

FIGURE 12 ASIA PACIFIC BIOINFORMATICS MARKET SEGMENTATION

FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE ASIA PACIFIC DENTAL LABMARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 GROWING APPLICATIONS OF BIOINFORMATICS AND LOW COST OF BIOINFORMATICS SEQUENCING ARE EXPECTED TO DRIVE THE MARKET FOR ASIA PACIFIC BIOINFORMATICS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 15 SERVICES SEGMENT ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC BIOINFORMATICS MARKET IN 2019 & 2026

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC BIOINFORMATICS MARKET

FIGURE 17 DECREASE IN COST OF PER BASE SEQUENCING

FIGURE 18 GROWING NEED FOR BIOINFORMATICS IN VITAL APPLICATIONS

FIGURE 19 ASIA PACIFIC BIOINFORMATICS MARKET: BY TYPE, 2021

FIGURE 20 ASIA PACIFIC BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 21 ASIA PACIFIC BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 22 ASIA PACIFIC BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 23 ASIA PACIFIC BIOINFORMATICS MARKET: BY SECTOR, 2021

FIGURE 24 ASIA PACIFIC BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)

FIGURE 25 ASIA PACIFIC BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)

FIGURE 26 ASIA PACIFIC BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE

FIGURE 27 ASIA PACIFIC BIOINFORMATICS MARKET: BY APPLICATION, 2021

FIGURE 28 ASIA PACIFIC BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 29 ASIA PACIFIC BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 30 ASIA PACIFIC BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 31 ASIA PACIFIC BIOINFORMATICS MARKET: BY PURCHASE MODE, 2021

FIGURE 32 ASIA PACIFIC BIOINFORMATICS MARKET: BY PURCHASE MODE, 2022-2029 (USD MILLION)

FIGURE 33 ASIA PACIFIC BIOINFORMATICS MARKET: BY PURCHASE MODE, CAGR (2022-2029)

FIGURE 34 ASIA PACIFIC BIOINFORMATICS MARKET: BY PURCHASE MODE, LIFELINE CURVE

FIGURE 35 ASIA PACIFIC BIOINFORMATICS MARKET: BY METHOD, 2021

FIGURE 36 ASIA PACIFIC BIOINFORMATICS MARKET: BY METHOD, 2022-2029 (USD MILLION)

FIGURE 37 ASIA PACIFIC BIOINFORMATICS MARKET: BY METHOD, CAGR (2022-2029)

FIGURE 38 ASIA PACIFIC BIOINFORMATICS MARKET: BY METHOD, LIFELINE CURVE

FIGURE 39 ASIA PACIFIC BIOINFORMATICS MARKET: BY END USER, 2021

FIGURE 40 ASIA PACIFIC BIOINFORMATICS MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 41 ASIA PACIFIC BIOINFORMATICS MARKET: BY END USER, CAGR (2022-2029)

FIGURE 42 ASIA PACIFIC BIOINFORMATICS MARKET: BY END USER, LIFELINE CURVE

FIGURE 43 ASIA-PACIFIC BIOINFORMATICS MARKET: SNAPSHOT (2021)

FIGURE 44 ASIA-PACIFIC BIOINFORMATICS MARKET: BY COUNTRY (2021)

FIGURE 45 ASIA-PACIFIC BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 46 ASIA-PACIFIC BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 47 ASIA-PACIFIC BIOINFORMATICS MARKET: BY TYPE (2022-2029)

FIGURE 48 ASIA PACIFIC BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

The market is segmented based on Asia-Pacific Bioinformatics Market, By Type (Knowledge Management Tools, Bioinformatics Software and Services), Sector (Medical Biotechnology, Academics, Animal Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Others), Application (Genomics & Drug Development, Proteomics, Evolutionary Studies, Agricultural Studies, Veterinary Science, Metabolomics, Transcriptomics and Others), Purchase Mode (Group Purchase and Individual Purchase), Method (Genomics and Proteomics) End-User, (Research and Academic Institutes, Clinical Research Organization, Biotech and Pharmaceutical Companies, Research Laboratories, Hospital and Others) - Industry Trends and Forecast to 2029. .
The Asia Pacific Apac Bioinformatics Market size was valued at USD 0.00 USD Billion in 2022.
The Asia Pacific Apac Bioinformatics Market is projected to grow at a CAGR of 17.8% during the forecast period of 2023 to 2029.
The major players operating in the market include , Thermo Fisher Scientific , Illumina , Agilent Technologies , QIAGEN SOPHiA GENETICS , BGI Eurofins Scientific , Waters Corporation , Partek ,orporated , Dassault Système , Bayer AG , PerkinElmer , Quest Diagnostics ,orporated , AstridBio Technologies , BioBam , Strand Life Science , GenoFAB ,.
The market report covers data from the China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific.